ArticleEndocrinology, diabetes & metabolism case reports2026
Tirzepatide reduced alcohol use in three patients with alcohol-associated liver disease, type 2 diabetes, and obesity.
Hiroki Takizawa et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.